Monogram Orthopaedics
MGRM
MGRM was delisted on the 6th of October, 2025.
0 hedge funds and large institutions have $0 invested in Monogram Orthopaedics in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 63 closing their positions.
10.44% less ownership
Funds ownership: 10.44% → 0% (-10%)
100% less funds holding
Funds holding: 63 → 0 (-63)
100% less capital invested
Capital invested by funds: $24.9M → $0 (-$24.9M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 63
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$7.13M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.64M |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
-$2.35M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.54M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.27M |
MGRM Hedge Fund Activity: Q4 2025 in Review
0 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in Monogram Orthopaedics (MGRM) for Q4 2025, worth a combined $0 — down 100% from $24.9M a quarter earlier.
Sellers outnumbered buyers: 63 funds closed out of MGRM and 0 opened new positions — a net loss of 63 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Tudor Investment Corp, exiting entirely with an estimated $7.13M sold.
- 0 institutional investors held Monogram Orthopaedics (MGRM) as of Q4 2025, down from 63 in Q3 2025.
- Funds reported $0 of Monogram Orthopaedics stock for Q4 2025, down 100% quarter-over-quarter.
- 0 funds opened new Monogram Orthopaedics positions in Q4 2025 and 63 closed out, a net change of -63 holders.
- The largest Monogram Orthopaedics seller in Q4 2025 was Tudor Investment Corp, an estimated $7.13M sold.
Based on aggregated 13F filings for Q4 2025.